Sculptor Capital’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Sculptor Capital’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-24,300	Closed	-$679K	–	355
2019 Q3	$679K	Sell	24,300 -1,800	-7%	-$29.2K	0.01%	245
2019 Q2	$368K	Buy	+26,100	New	+$248K	﹤0.01%	244

Sculptor Capital's DOVA Position: Q4 2019 in Review

Sculptor Capital sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 24,300 shares — an estimated $679K sold.

Sculptor Capital first reported a position in DOVA in Q2 2019 and held it in 2 quarters. The position peaked at $679K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Sculptor Capital reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Sculptor Capital sold 24,300 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $679K.
Sculptor Capital first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
Sculptor Capital's Dova Pharmaceuticals, Inc. Common Stock position peaked at $679K in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Sculptor Capital's 13F filing for Q4 2019, filed 14 Feb 2020.